A Study of BPI-452080 in Subjects With Solid Tumors
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Dingwei Ye, Ph.D
Fudan University
Principal Investigator - Jian Zhang, Ph.D
Fudan University
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Fudan University Shanghai Cancer Center
Shanghai, Shanghai Municipality, China
- West China Hospital of Sichuan University
Chengdu, China
- Zhejiang Cancer Hospital
Hangzhou, China
- Hunan Cancer Hospital
Hunan, China
- Union Hospital Tongji Medical College Huazhong University of Science and Technology
Wuhan, China
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 28 Apr 2023
- Primary completion
- 25 Mar 2025
- Completion
- 31 Oct 2025
- Last update posted
- 6 May 2023
- Registered enrollment
- 87
- Registry id
- NCT05843305
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.